ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LGND Ligand Pharmaceuticals Incorporated

84.91
-2.37 (-2.72%)
May 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 125,663
Bid Price 83.05
Ask Price 87.82
News -
Day High 87.475

Low
49.24

52 Week Range

High
94.57

Day Low 83.17
Company Name Stock Ticker Symbol Market Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.37 -2.72% 84.91 18:00:04
Open Price Low Price High Price Close Price Prev Close
87.22 83.17 87.475 84.91 87.28
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,241 125,663 $ 84.37 $ 10,602,540 - 49.24 - 94.57
Last Trade Time Type Quantity Stock Price Currency
16:07:29 35 $ 84.91 USD

Ligand Pharmaceuticals Incorporated Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.5B 17.71M - 131.31M 52.15M 2.95 28.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Ligand Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LGND Message Board. Create One! See More Posts on LGND Message Board See More Message Board Posts

Historical LGND Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week85.4088.5283.1786.50116,807-0.49-0.57%
1 Month70.2488.5269.5180.07156,15714.6720.89%
3 Months85.0688.5267.7276.05176,759-0.15-0.18%
6 Months59.9694.5757.0074.49151,95724.9541.61%
1 Year75.4794.5749.2470.50125,6529.4412.51%
3 Years123.90169.9849.2493.84144,882-38.99-31.47%
5 Years113.84219.7549.24105.48237,761-28.93-25.41%

Ligand Pharmaceuticals Description

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.